Entity
  • Exeliom Biosciences

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,747
  • Activities

  • Technologies

  • Entity types

  • Location

    67 Rue des Godrans, 21000 Dijon, France

    Dijon

    France

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged corporates

    11
    4 9
  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Crossing the next frontier, to give you a fair chance to fight

    Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms.

    Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation

  • Original language

    Crossing the next frontier, to give you a fair chance to fight

    Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms.

  • exeliom

    At Exeliom Biosciences, we develop novel therapeutic approaches to unleashthe therapeutic potential of key players in the Microbiome - Host interactions to fightimmune-mediated diseases, starting with inflammatory bowel diseases

  • https://www.exeliombio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

31 Jan 2023


Similar entities
Loading...
Loading...
Social network dynamics